RECENT COMMENTS

Vadim I. Shapoval: Oncopatients die because doctors use harmful ineffective antitumor drugs and methods. However, these [...]   »Read more

Kathy Redmond: Readers may have noticed that ESO has deleted a number of comments on this article. This is because [...]   »Read more

Pongsri (Sex and cancer): I teach body image and sexuality in cancer survivors for specialty 4 month cancer nurse program. Thi [...]   »Read more

DR Jennifer L Scott (Sex and cancer): Togehter with my colleague Prof Karen Kayser I have published a review of RCT of interventions to en [...]   »Read more

Dr O. Abimbola Oluwatosin (Sex and cancer): I teach sexuality in Nursing at post graduate level. This article is very useful and will be added t [...]   »Read more

Editorial

Issue 36
When the trial you need is just over the border
Issue 35
Stop excluding male patients
Issue 34
A partnership with potential
Issue 33
Rare cancers in Europe - tacking a common problem
Issue 32
Talking the same language
Issue 31
Prostate cancer screening: a question of common sense
Issue 30
It's about living, not just surviving
Issue 29
Europe's nurses: an untapped resource 
Issue 28
Senior, elderly, geriatric: we are all getting older 
Issue 27
A window of opportunity 
Issue 26
ECCO–ESMO: a powerful partnership 
Issue 25
A question of human dignity 
Issue 24
Shameful statistics of pain 
Issue 23
Diet and exercise: it's time to act on the evidence 
Issue 22
Men's health matters too 
Issue 21
Tackling the adherence crisis 
Issue 20
Passing on the baton 
Issue 19
Our responsability to survivors 
Issue 18
Elderly patients deserve better 
Issue 17
The challege for St Gallen 
Issue 16
A question of public trust 
Issue 15
The write stuff 
Issue 14
Making rights a reality 
Issue 13
UICC - taking on mission impossible 
Issue 12
Getting serious about e-qual @ccess 
Issue 11
We don't have to be a year behind
Issue 10
Hope or hype? 
Issue 9
A European report card 
Issue 8
A stronger voice within Europe 
Issue 7
A quiet revolution 
Issue 6
Balancing safety against need 
Issue 5
The power of words 
Issue 4
End this secrecy over clinical trials 
Issue 3
Too valuable to put a price on 
Issue 2
Our partnership with patients 
Issue 1
Welcome to our World 

 
 

e-ESO.net

E-eso

Online educational resources Including e-grandrounds, weekly online meetings in collaboration with Nature Reviews Clinical Oncology - CME accredited!

Next live sessions:

GR114 - Do small node negative HER-2 positive tumors deserve a better treatment?

GR115 - Standard management of patients with chronic myeloid leukemia in the era of tirosine kinase inhibitors

GR116 - Survivorship issues and breast cancer

The website is supported by an unrestricted educational grant provided by:

Founding sponsor

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
ECPC
ECPC
Europa Donna
Europa
Donna
Europa Uomo
Europa
Uomo
EONS
EONS
SIOG
SIOG
The challenge Fund
The
Challenge
Fund
Seno network
SenoNetwork
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, AstraZeneca, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck and Novartis.